Biocon Group participated at the recently concluded Global Bio-India 2024 (GBI 2024), a Government of India initiative under the Department of Biotechnology. The 4th Edition of the GBI 2024, held during September 12-14 in New Delhi witnessed a large representation from key stakeholders in the biotechnology sector, demonstrating India’s biotech potential to the world. In … Continue reading Global Bio India 2024: Biocon Group Playing a Critical Role in Realizing India’s Bioeconomy Potential
Biocon Biologics off to a solid start in Q1 FY25, powered byproduct sales & market shares
The successful integration of the acquired Biosimilars business dominated the Biocon Biologics growth story last year. In fiscal year 2024-25 (FY25), we have turned our focus to consolidating the acquired business and paving the way for future growth. Our performance in the first quarter of FY25 gives us confidence that we are on the right … Continue reading Biocon Biologics off to a solid start in Q1 FY25, powered byproduct sales & market shares
A Blog by Biocon 